Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matthew Brendon Might, Ph.D.

Title
Institution
Department
Address

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U54OD030167 (YODER, BRADLEY K.) Sep 10, 2020 - Aug 31, 2025
    NIH
    UAB Pilot Center for Precision Animal Modeling (C-PAM)
    Role: Co-Principal Investigator
  2. OT2TR003435 (BYRD, WILLIAM E) Jan 24, 2020 - Jan 23, 2022
    NIH
    Doc Sherlock: An Autonomous Relay Agent for Discovering the Unknown Knowns in Precision Medicine
    Role: Co-Principal Investigator
  3. OT2TR002517 (MIGHT, MATTHEW BRENDON) Dec 29, 2017 - Dec 28, 2019
    NIH
    Biomedical Data Translator Technical Feasibility Assessment of Reasoning Tool: University of Alabama at Birmingham
    Role: Principal Investigator
  4. U01HG007530 (KOHANE, ISAAC S.) Dec 20, 2013 - Jun 30, 2022
    NIH
    Coordinating Center for the Undiagnosed Disease Network Phase II
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Nickols NG, Goetz MB, Graber CJ, Bhattacharya D, Soo Hoo G, Might M, Goldstein DB, Wang X, Ramoni R, Myrie K, Tran S, Ghayouri L, Tsai S, Geelhoed M, Makarov D, Becker DJ, Tsay JC, Diamond M, George A, Al-Ajam M, Belligund P, Montgomery RB, Mostaghel EA, Sulpizio C, Mi Z, Dematt E, Tadalan J, Norman LE, Briones D, Clise CE, Taylor ZW, Huminik JR, Biswas K, Rettig MB. Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial. Trials. 2021 Jul 05; 22(1):431. PMID: 34225789.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  2. Mannucci I, Dang NDP, Huber H, Murry JB, Abramson J, Althoff T, Banka S, Baynam G, Bearden D, Beleza-Meireles A, Benke PJ, Berland S, Bierhals T, Bilan F, Bindoff LA, Braathen GJ, Busk ØL, Chenbhanich J, Denecke J, Escobar LF, Estes C, Fleischer J, Groepper D, Haaxma CA, Hempel M, Holler-Managan Y, Houge G, Jackson A, Kellogg L, Keren B, Kiraly-Borri C, Kraus C, Kubisch C, Le Guyader G, Ljungblad UW, Brenman LM, Martinez-Agosto JA, Might M, Miller DT, Minks KQ, Moghaddam B, Nava C, Nelson SF, Parant JM, Prescott T, Rajabi F, Randrianaivo H, Reiter SF, Schuurs-Hoeijmakers J, Shieh PB, Slavotinek A, Smithson S, Stegmann APA, Tomczak K, Tveten K, Wang J, Whitlock JH, Zweier C, McWalter K, Juusola J, Quintero-Rivera F, Fischer U, Yeo NC, Kreienkamp HJ, Lessel D. Genotype-phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders. Genome Med. 2021 May 21; 13(1):90. PMID: 34020708.
    Citations: 1     Fields:    
  3. Pradhan M, Farkhondeh A, Cheng YS, Xu M, Beers J, Zou J, Liu C, Might M, Rodems S, Baumgärtel K, Zheng W. An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene. Stem Cell Res. 2021 Jul; 54:102400. PMID: 34051448.
    Citations:    Fields:    
  4. LeBlanc K, Kelley EG, Nagy A, Bater J, Berro T, McGuinness MA, Studwell C, Might M. Rare disease patient matchmaking: development and outcomes of an internet case-finding strategy in the Undiagnosed Diseases Network. Orphanet J Rare Dis. 2021 05 10; 16(1):210. PMID: 33971915.
    Citations:    Fields:    Translation:Humans
  5. Tao D, Xu M, Farkhondeh A, Burns AP, Rodems S, Might M, Zheng W, LeClair CA. High-throughput protein modification quantitation analysis using intact protein MRM and its application on hENGase inhibitor screening. Talanta. 2021 Aug 15; 231:122384. PMID: 33965046.
    Citations:    Fields:    Translation:Humans
  6. Crouse AB, Grimes T, Li P, Might M, Ovalle F, Shalev A. Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes. Front Endocrinol (Lausanne). 2020; 11:600439. PMID: 33519709.
    Citations: 17     Translation:Humans
  7. Khomtchouk BB, Tran DT, Vand KA, Might M, Gozani O, Assimes TL. Cardioinformatics: the nexus of bioinformatics and precision cardiology. Brief Bioinform. 2020 12 01; 21(6):2031-2051. PMID: 31802103.
    Citations: 2     Fields:    
  8. East KM, Kelley WV, Cannon A, Cochran ME, Moss IP, May T, Nakano-Okuno M, Sodeke SO, Edberg JC, Cimino JJ, Fouad M, Curry WA, Hurst ACE, Bowling KM, Thompson ML, Bebin EM, Johnson RD, Cooper GM, Might M, Barsh GS, Korf BR. A state-based approach to genomics for rare disease and population screening. Genet Med. 2021 04; 23(4):777-781. PMID: 33244164.
    Citations:    Fields:    Translation:Humans
  9. Rubinstein YR, Robinson PN, Gahl WA, Avillach P, Baynam G, Cederroth H, Goodwin RM, Groft SC, Hansson MG, Harris NL, Huser V, Mascalzoni D, McMurry JA, Might M, Nellaker C, Mons B, Paltoo DN, Pevsner J, Posada M, Rockett-Frase AP, Roos M, Rubinstein TB, Taruscio D, van Enckevort E, Haendel MA. The case for open science: rare diseases. JAMIA Open. 2020 Oct; 3(3):472-486. PMID: 33426479.
    Citations: 1     
  10. Crouse A, Grimes T, Li P, Might M, Ovalle F, Shalev A. METFORMIN USE IS ASSOCIATED WITH REDUCED MORTALITY IN A DIVERSE POPULATION WITH COVID-19 AND DIABETES. medRxiv. 2020 Jul 31. PMID: 32766607.
    Citations: 1     
  11. Tran DT, Bhaskara A, Kuberan B, Might M. A graph-based algorithm for RNA-seq data normalization. PLoS One. 2020; 15(1):e0227760. PMID: 31978105.
    Citations:    Fields:    
  12. Queralt-Rosinach N, Stupp GS, Li TS, Mayers M, Hoatlin ME, Might M, Good BM, Su AI. Structured reviews for data and knowledge-driven research. Database (Oxford). 2020 01 01; 2020. PMID: 32283553.
    Citations: 1     Fields:    Translation:HumansAnimals
  13. Crouse A, Nakano-Okuno M, Might M, May T. N-of-1 Precision Medicine and Research Oversight. Am J Bioeth. 2019 Aug; 19(8):36-37. PMID: 31544631.
    Citations:    Fields:    Translation:Humans
  14. Yang S, Cheng YS, Li R, Pradhan M, Hong J, Beers J, Zou J, Liu C, Might M, Rodems S, Zheng W. An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene. Stem Cell Res. 2019 08; 39:101496. PMID: 31326749.
    Citations:    Fields:    Translation:HumansCells
  15. Farkhondeh A, Li R, Gorshkov K, Chen KG, Might M, Rodems S, Lo DC, Zheng W. Induced pluripotent stem cells for neural drug discovery. Drug Discov Today. 2019 04; 24(4):992-999. PMID: 30664937.
    Citations: 12     Fields:    Translation:HumansCells
  16. Li R, Pradhan M, Xu M, Baskfield A, Farkhondeh A, Cheng YS, Beers J, Zou J, Liu C, Might M, Rodems S, Zheng W. Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene. Stem Cell Res. 2019 01; 34:101362. PMID: 30612078.
    Citations:    Fields:    Translation:HumansCells
  17. Tran DT, Zhang T, Stutsman R, Might M, Desai UR, Kuberan B. anexVis: visual analytics framework for analysis of RNA expression. Bioinformatics. 2018 07 15; 34(14):2510-2512. PMID: 29506198.
    Citations:    Fields:    Translation:Humans
  18. Vasilevsky NA, Foster ED, Engelstad ME, Carmody L, Might M, Chambers C, Dawkins HJS, Lewis J, Della Rocca MG, Snyder M, Boerkoel CF, Rath A, Terry SF, Kent A, Searle B, Baynam G, Jones E, Gavin P, Bamshad M, Chong J, Groza T, Adams D, Resnick AC, Heath AP, Mungall C, Holm IA, Rageth K, Brownstein CA, Shefchek K, McMurry JA, Robinson PN, Köhler S, Haendel MA. Plain-language medical vocabulary for precision diagnosis. Nat Genet. 2018 04; 50(4):474-476. PMID: 29632381.
    Citations: 10     Fields:    Translation:Humans
  19. Atkin TA, Maher CM, Gerlach AC, Gay BC, Antonio BM, Santos SC, Padilla KM, Rader J, Krafte DS, Fox MA, Stewart GR, Petrovski S, Devinsky O, Might M, Petrou S, Goldstein DB. A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsy. Epilepsia. 2018 04; 59(4):802-813. PMID: 29574705.
    Citations: 6     Fields:    Translation:HumansCells
  20. Owings KG, Lowry JB, Bi Y, Might M, Chow CY. Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches. Hum Mol Genet. 2018 03 15; 27(6):1055-1066. PMID: 29346549.
    Citations: 14     Fields:    Translation:AnimalsCells
  21. Bi Y, Might M, Vankayalapati H, Kuberan B. Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-ß-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease. Bioorg Med Chem Lett. 2017 07 01; 27(13):2962-2966. PMID: 28512024.
    Citations: 9     Fields:    Translation:HumansCells
  22. Might M, Might CC. What happens when N?=?1 and you want plus 1? Prenat Diagn. 2017 Jan; 37(1):70-72. PMID: 27885678.
    Citations: 3     Fields:    Translation:Humans
  23. Lambertson KF, Damiani SA, Might M, Shelton R, Terry SF. Participant-driven matchmaking in the genomic era. Hum Mutat. 2015 Oct; 36(10):965-73. PMID: 26252162.
    Citations: 17     Fields:    Translation:Humans
  24. Might M, Wilsey M. The shifting model in clinical diagnostics: how next-generation sequencing and families are altering the way rare diseases are discovered, studied, and treated. Genet Med. 2014 Oct; 16(10):736-7. PMID: 24651604.
    Citations: 26     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Might's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (98)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.